| ABIVAX SA SP.ADR O.N. |
| USA |
| Gesundheit |
| US00370M1036 / A3EWCP |
| 2X10 (Frankfurt) / ABVX (NASDAQ) |
| FRA:2X10, ETR:2X10, 2X10:GR, NASDAQ:ABVX |
| - |
| https://www.abivax.com/ |
|
ABIVAX Société Anonyme, a clinical-stage biotech..
>Volltext.. |
| 7894.96 Mio. EUR |
| 7351.02 Mio. EUR |
| - |
| - |
| - |
| - |
| 45.9 Mio. EUR |
| 589.84 Mio. EUR |
| - |
| 7.49 |
| - |
| - |
| - |
| - |
| - |
| - |
| ABIVAX ADR, ABIVAX |
| 18.12.25 |
|